BioCatalyst

HM15211 — catalyst calendar

1 verified catalyst event(s) referencing HM15211, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-06-27
in 5d
ESTIMATED
 READOUT
Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide)
Phase 2 · NASH - Nonalcoholic Steatohepatitis
 Hanmi Pharmaceutical Company Limit HM15211 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.